Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
S100 calcium-binding protein Z (S100Z) is a member of the S100 protein family, a group of small, EF-hand, calcium-binding proteins expressed in vertebrates[1][2]. Most S100 proteins are cellular signals modulators, responding to changes in intracellular calcium concentrations and interacting with a diverse range of protein partners, including enzymes, cytoskeletal proteins, transcription factors, and receptors[1][2]. While S100Z shares the general architecture and binding properties of the family, its specific expression, partner proteins, and functional roles remain unclear because it is one of the least studied S100 proteins. So far, there is no evidence of therapeutic targeting, direct disease association, or utility as a biomarker for S100Z. S100 proteins broadly regulate processes such as cell cycle, apoptosis, differentiation, and motility, and several family members play extracellular roles via signaling pathways such as RAGE and TLRs, but direct evidence for S100Z’s involvement in these functions is currently lacking[1][2].
None known (no drugs targeting S100Z)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on S100 calcium-binding protein Z (S100Z).